| Tretinoin | Approved Investigational Nutraceutical | SPON2 | 10417 |
downregulated | Tretinoin results in decreased expression of SPON2 mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPON2 | 10417 |
upregulated | Tretinoin results in increased expression of SPON2 mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPP1 | 6696 |
upregulated | Tretinoin results in increased expression of SPP1 mRNA | 4q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPRR1B | 6699 |
downregulated | Tretinoin analog results in decreased expression of SPRR1B mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPRR1B | 6699 |
downregulated | Tretinoin metabolite results in decreased expression of SPRR1B mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPRR1B | 6699 |
downregulated | Tretinoin results in decreased expression of SPRR1B mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPRY1 | 10252 |
upregulated | Tretinoin results in increased expression of SPRY1 mRNA | 4q28.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPRY2 | 10253 |
downregulated | Tretinoin results in decreased expression of SPRY2 mRNA | 13q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPRYD4 | 283377 |
downregulated | Tretinoin results in decreased expression of SPRYD4 mRNA | 12q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPSB1 | 80176 |
upregulated | Tretinoin results in increased expression of SPSB1 mRNA | 1p36.22 | |
| Tretinoin | Approved Investigational Nutraceutical | SPSB2 | 84727 |
upregulated | Tretinoin results in increased expression of SPSB2 mRNA | 12p13.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SPTB | 6710 |
downregulated | Tretinoin results in decreased expression of SPTB mRNA | 14q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SPTBN1 | 6711 |
upregulated | Tretinoin results in increased expression of SPTBN1 mRNA | 2p16.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPTBN2 | 6712 |
downregulated | Tretinoin results in decreased expression of SPTBN2 mRNA | 11q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SPTSSB | 165679 |
downregulated | Tretinoin results in decreased expression of SPTSSB mRNA | 3q26.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SPX | 80763 |
upregulated | Tretinoin results in increased expression of SPX mRNA | 12p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | SQSTM1 | 8878 |
upregulated | Tretinoin results in increased expression of SQSTM1 mRNA | 5q35.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SRA1 | 10011 |
upregulated | Tretinoin results in increased expression of SRA1 mRNA | 5q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SREBF2 | 6721 |
downregulated | Tretinoin results in decreased expression of SREBF2 mRNA | 22q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | SREK1IP1 | 285672 |
downregulated | Tretinoin results in decreased expression of SREK1IP1 mRNA | 5q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | SRI | 6717 |
downregulated | Tretinoin results in decreased expression of SRI mRNA | 7q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SRI | 6717 |
upregulated | Tretinoin results in increased expression of SRI mRNA | 7q21.12 | |
| Tretinoin | Approved Investigational Nutraceutical | SRM | 6723 |
downregulated | Tretinoin results in decreased expression of SRM mRNA | 1p36.22 | |
| Tretinoin | Approved Investigational Nutraceutical | SRPK1 | 6732 |
downregulated | Tretinoin results in decreased expression of SRPK1 mRNA | 6p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | SRPX | 8406 |
upregulated | Tretinoin results in increased expression of SRPX mRNA | Xp11.4 | |